Examples of using Combination with trastuzumab in English and their translations into Italian
{-}
-
Medicine
-
Colloquial
-
Official
-
Financial
-
Ecclesiastic
-
Ecclesiastic
-
Computer
-
Programming
-
Official/political
medium in vitro and was synergistic in combination with trastuzumab in these cell lines.
in 62% of patients who received lapatinib in combination with trastuzumab.
Perjeta in combination with trastuzumab and docetaxel was not associated with a greater incidence of symptomatic left ventricular systolic dysfunction(LVD)
that it wishes to withdraw its application for a new indication for Taxotere/ Docetaxel Winthrop, to add the treatment of patients with operable breast cancer whose tumours overexpress HER2 in combination with trastuzumab, with or without carboplatin.
from the neoadjuvant trials NEOSPHERE and TRYPHAENA, in which Perjeta was given in combination with trastuzumab and chemotherapy to patients with early breast cancer.
Phase II study to evaluate pertuzumab in combination with trastuzumab and standard neoadjuvant anthracycline-based chemotherapy in patients with HER2-positive, locally advanced, inflammatory,
149 patients who received lapatinib in combination with trastuzumab and 654 patients who received lapatinib in combination with letrozole see section 5.1.
In combination with trastuzumab for advanced or metastatic cancer that does not respond to hormones(hormone receptor-negative disease),
did not recommend a marketing authorisation for Taxotere/ Docetaxel Winthrop in the treatment of patients with operable breast cancer whose tumours overexpress HER2 in combination with trastuzumab, with or without carboplatin.
Taxespira in combination with trastuzumab.
TAXOTERE in combination with trastuzumab.
Docetaxel in combination with trastuzumab.
DOCETAXEL KABI in combination with trastuzumab.
Docetaxel Winthrop in combination with trastuzumab.
Patients treated with docetaxel in combination with trastuzumab.
Perjeta in combination with trastuzumab and docetaxel.
Patients treated with docetaxel in combination with trastuzumab.
The most common ADRs(≥ 50%) seen with Perjeta in combination with trastuzumab and docetaxel were diarrhoea, alopecia and neutropenia.
The efficacy and safety of lapatinib in combination with trastuzumab in metastatic breast cancer were evaluated in a randomised trial.
When patients are candidates for treatment with docetaxel in combination with trastuzumab, they should undergo baseline cardiac assessment.